DUBLIN, Mar 22, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Intraosseous Infusion Devices Market 2017-2021" report to their offering.
The global intraosseous infusion devices market to grow at a CAGR of 4.67% during the period 2017-2021.
One trend in the market is the growing use of intraosseous infusion devices in pediatric cases. The adoption of intraosseous infusion devices for interventions and therapies has increased considerably due to safety, rapid, and efficient fluid flow. The advances in intraosseous devices have allowed their use in pediatrics. For instance, the EZ-IO needle is available in different gauges for both pediatric and adult applications. Accessing the intravenous ROA in critically ill, injured infants, or young children is difficult or nearly impossible. This will delay the administration of critically needed medications or fluids. As the intraosseous ROA provides direct access to the marrow or medullary cavities in long bones, it is useful in gaining vascular access within minutes and is lifesaving. Intraosseous infusion devices are widely used as an alternative in severely hypovolemic children.
According to the report, one driver in the market is the increased incidence of chronic diseases leading to hospitalization. The sedentary lifestyle negatively affects the homeostasis of the body, making people susceptible to various disorders such as cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, end-stage renal disease, urology disorders, and other chronic illnesses.
According to multiple research studies, each year, about 970-990 million people worldwide have elevated blood pressure, of which 9.4-9.6 million deaths occur. Stroke causes 51% of these deaths, and the rest is caused by cardiac disorders. Diabetes causes greater complications with cardiovascular diseases. According to multiple research statistics, in 2015, more than 415 million adults aged 20-79 were affected by diabetes worldwide, including 193 million who were underdiagnosed, and the number is expected to reach 642 million by 2040.
- Cook Medical
- Pyng Medical
- PerSys Medical
Other prominent vendors
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research methodology
PART 04: Introduction
PART 05: Intraosseous infusion device: An overview
PART 06: Market landscape
PART 07: Market segmentation by product type
PART 08: Market segmentation by end-user
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/r3hq2r/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-intraosseous-infusion-devices-market-to-grow-at-a-cagr-of-467-with-bd-cook-medical-pyng-medical-persys-medical--teleflex-dominating-300427761.html
SOURCE Research and Markets